Nisa Investment Advisors
NVCR icon

Nisa Investment Advisors’s NovoCure NVCR Stock Holding History

Nisa Investment Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.3K Buy
4,525
+3,679
+435% +$46K ﹤0.01% 1673
2025
Q4 		$10.9K Sell
846
-215
-20% -$2.76K ﹤0.01% 2173
2025
Q3 		$13.7K Sell
1,061
-3,031
-74% -$40.5K ﹤0.01% 2156
2025
Q2 		$72.8K Sell
4,092
-197
-5% -$3.43K ﹤0.01% 1497
2025
Q1 		$76.4K Sell
4,289
-32
-0.7% -$727 ﹤0.01% 1468
2024
Q4 		$129K Buy
4,321
+1,575
+57% +$33.3K ﹤0.01% 1405
2024
Q3 		$42.9K Sell
2,746
-31
-1% -$562 ﹤0.01% 1680
2024
Q2 		$47.6K Buy
+2,777
New +$48.8K ﹤0.01% 1684
2023
Q2 		– Sell
-12,334
Closed -$742K – 2847
2023
Q1 		$742K Buy
12,334
+3,918
+47% +$313K 0.01% 948
2022
Q4 		$617K Sell
8,416
-1,064
-11% -$80.1K ﹤0.01% 1059
2022
Q3 		$718K Buy
9,480
+7,795
+463% +$608K 0.01% 918
2022
Q2 		$117K Sell
1,685
-775
-32% -$58.4K ﹤0.01% 1458
2022
Q1 		$204K Hold
2,460
– – ﹤0.01% 1371
2021
Q4 		$169K Sell
2,460
-1,258
-34% -$126K ﹤0.01% 1330
2021
Q3 		$432 Sell
3,718
-4,115
-53% -$622K ﹤0.01% 1157
2021
Q2 		$1.74K Buy
7,833
+474
+6% +$92.2K 0.01% 757
2021
Q1 		$973 Buy
7,359
+2,506
+52% +$396K 0.01% 963
2020
Q4 		$840K Buy
4,853
+2,458
+103% +$336K 0.01% 999
2020
Q3 		$267K Hold
2,395
– – ﹤0.01% 1228
2020
Q2 		$142K Sell
2,395
-505
-17% -$33.2K ﹤0.01% 1359
2020
Q1 		$195K Buy
2,900
+570
+24% +$45K ﹤0.01% 1202
2019
Q4 		$196K Buy
2,330
+140
+6% +$11.3K ﹤0.01% 1328
2019
Q3 		$164K Buy
2,190
+90
+4% +$7.2K ﹤0.01% 1370
2019
Q2 		$133K Hold
2,100
– – ﹤0.01% 1381
2019
Q1 		$101K Sell
2,100
-100
-5% -$4.81K ﹤0.01% 1430
2018
Q4 		$74K Buy
2,200
+500
+29% +$18.3K ﹤0.01% 1409
2018
Q3 		$89K Hold
1,700
– – ﹤0.01% 1407
2018
Q2 		$53K Sell
1,700
-10,000
-85% -$278K ﹤0.01% 1442
2018
Q1 		$243K Hold
11,700
– – ﹤0.01% 1186
2017
Q4 		$236K Sell
11,700
-300
-3% -$5.78K ﹤0.01% 1225
2017
Q3 		$238K Buy
12,000
+2,000
+20% +$39.3K ﹤0.01% 1211
2017
Q2 		$126K Buy
+10,000
New +$129K ﹤0.01% 1319

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Nisa Investment Advisors's NVCR Position: Q1 2026 in Review

Nisa Investment Advisors increased its NovoCure (NVCR) stake by 435% in Q1 2026, buying an estimated $46K and bringing the position to 4,525 shares worth $49.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1673.

Nisa Investment Advisors first reported a position in NVCR in Q2 2017 and has held it in 32 quarters since. The position peaked at $840K in Q4 2020. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Nisa Investment Advisors held 4,525 shares of NovoCure worth $49.3K as of Q1 2026.
  • Nisa Investment Advisors bought 3,679 NovoCure shares in Q1 2026, an estimated $46K.
  • NovoCure made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1673 holding.
  • Nisa Investment Advisors first reported a position in NovoCure in Q2 2017 and has held it in 32 quarters since.
  • Nisa Investment Advisors's NovoCure position peaked at $840K in Q4 2020.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.